Observational studyJournal of endocrinological investigation2026
Delirium in diabetic ketoacidosis: a multicenter observational study of occurrence, associated factors and outcomes from 578,204 hospitalizations.
Observational study in Journal of endocrinological investigation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
backgroundDelirium is a neuropsychiatric syndrome in hospitalized diabetic ketoacidosis (DKA) patients and is associated with poor clinical outcomes. However, multicenter national data on its prevalence and associated factors in this population are lacking.
methodsAdult patients with DKA were identified from the National Inpatient Sample (2013-2022) and stratified by delirium occurrence. Multivariable logistic regression identified delirium associated factors, including demographics, institutional characteristics, comorbidities, and complications.
resultsIn 578,204 DKA-related hospitalizations, delirium was documented in 6,161 hospitalizations (1.1%), increasing from 0.5% in 2013 to 1.4% in 2022. Multivariable analysis demonstrated that patients aged ≥ 45 years, ≥ 2 comorbidities, large hospital and teaching hospital were associated with higher odds of delirium. Comorbidities including alcohol use, congestive heart failure, coagulopathy, depression, liver disease, other neurological disorders, psychoses, weight loss, and dementia correlated with higher delirium odds. Complications such as pulmonary embolism, sepsis, stroke, urinary tract infection, pneumonia, acute myocardial infarction, and acute kidney injury were also associated with delirium. Patients with delirium had prolonged median hospitalization duration (8 vs. 3 days), higher healthcare costs ($82,196 vs. $29,417), and higher mortality (6.4% vs.3.2%) (P < 0.001).
conclusionAlthough delirium occurrence is modest in DKA patients, it is associated with adverse clinical outcome. Healthcare providers should identify high-risk populations and enhance surveillance protocols. Further prospective studies are needed to clarify these associations and develop preventive strategies.
Indexed as
Identifiers
42418109What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.